Downregulation of STAT3, β-Catenin, and Notch-1 by Single and Combinations of siRNA Treatment Enhance Chemosensitivity of Wild Type and Doxorubicin Resistant MCF7 Breast Cancer Cells to Doxorubicin
Combinatorial therapeutic strategies using siRNA and small molecules to eradicate tumors are emerging. Targeting multiple signaling pathways decreases the chances of cancer cells switching and adapting new signaling processes that may occur when using a single therapeutic modality. Aberrant function...
Main Authors: | Walhan Alshaer, Dana A. Alqudah, Suha Wehaibi, Duaa Abuarqoub, Malek Zihlif, Ma’mon M. Hatmal, Abdalla Awidi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/15/3696 |
Similar Items
-
Mirror siRNAs loading for dual delivery of doxorubicin and autophagy regulation siRNA for multidrug reversing chemotherapy
by: Bo Yang, et al.
Published: (2020-10-01) -
Novel functionalized nanoparticles for tumor-targeting co-delivery of doxorubicin and siRNA to enhance cancer therapy
by: Xia Y, et al.
Published: (2017-12-01) -
Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
by: Florian Gauthier, et al.
Published: (2020-06-01) -
Quick synthesis of a novel combinatorial delivery system of siRNA and doxorubicin for a synergistic anticancer effect
by: Chen M, et al.
Published: (2019-05-01) -
Targeting cell cycle protein in gastric cancer with CDC20siRNA and anticancer drugs (doxorubicin and quercetin) co-loaded cationic PEGylated nanoniosomes
by: Hemati M, et al.
Published: (2019-08-01)